Koninklijke DSM N.V.
KDSKF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $7,590,000 | $8,390,000 | $9,204,000 | $8,106,000 |
| % Growth | -9.5% | -8.8% | 13.5% | – |
| Cost of Goods Sold | $6,021,000 | $5,700,000 | $6,040,000 | $5,330,000 |
| Gross Profit | $1,569,000 | $2,690,000 | $3,164,000 | $2,776,000 |
| % Margin | 20.7% | 32.1% | 34.4% | 34.2% |
| R&D Expenses | $352,000 | $295,000 | $323,000 | $398,000 |
| G&A Expenses | $619,000 | $538,000 | $517,000 | $469,000 |
| SG&A Expenses | $1,670,000 | $1,773,000 | $1,787,000 | $1,618,000 |
| Sales & Mktg Exp. | $1,051,000 | $1,235,000 | $1,270,000 | $1,149,000 |
| Other Operating Expenses | -$4,000 | $7,000 | $0 | $0 |
| Operating Expenses | $2,018,000 | $2,046,000 | $2,139,000 | $2,100,000 |
| Operating Income | -$412,000 | $682,000 | $1,021,000 | $662,000 |
| % Margin | -5.4% | 8.1% | 11.1% | 8.2% |
| Other Income/Exp. Net | -$58,000 | -$88,000 | -$23,000 | -$67,000 |
| Pre-Tax Income | -$470,000 | $594,000 | $998,000 | $595,000 |
| Tax Expense | -$16,000 | $124,000 | $168,000 | $106,000 |
| Net Income | $2,318,000 | $1,700,000 | $1,676,000 | $506,000 |
| % Margin | 30.5% | 20.3% | 18.2% | 6.2% |
| EPS | 13.41 | 9.8 | 9.68 | 2.91 |
| % Growth | 36.8% | 1.2% | 232.6% | – |
| EPS Diluted | 13.38 | 9.77 | 9.63 | 2.89 |
| Weighted Avg Shares Out | 172,827 | 172,827 | 172,648 | 171,536 |
| Weighted Avg Shares Out Dil | 173,304 | 173,304 | 173,395 | 172,432 |
| Supplemental Information | – | – | – | – |
| Interest Income | $118,000 | $22,000 | $3,000 | $17,000 |
| Interest Expense | $141,000 | $130,000 | $110,000 | $98,000 |
| Depreciation & Amortization | $636,000 | $652,000 | $681,000 | $740,000 |
| EBITDA | $307,000 | $1,376,000 | $1,396,000 | $1,433,000 |
| % Margin | 4% | 16.4% | 15.2% | 17.7% |